Indrayani Biotech Ltd — Board Meeting, 12-06-2025: Board Meeting

Indrayani Biotech Limited has announced a board meeting to approve the audited standalone financial results for the quarter and year ended March 31, 2025, with the auditors issuing an unmodified opinion. Revenue from operations stood at Rs. 928.31 lakh for the quarter, with a profit after tax of Rs. 111.41 lakh. The company’s balance sheet shows total assets of Rs. 130.68 Cr and equity of Rs. 55.33 Cr. Cash flow from operations improved significantly to Rs. 17.35 Cr. Additionally, Mr. V Santhanakrishnan has resigned as Company Secretary and Compliance Officer to pursue other opportunities.